I was impressed with the clarity of the reporting. New appointment presumably.My back of envelope on their numbers says net cash position (incl, tax, hedge, inventory) was A$72mm, just over 12 cps.50% cash and rising.EL
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
